CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,909,000 | -94.9% | 287,249 | -92.7% | 0.00% | -92.6% |
| Q1 2022 | $76,702,000 | -43.0% | 3,911,347 | -0.3% | 0.05% | -27.0% |
| Q4 2021 | $134,610,000 | -37.5% | 3,923,340 | -0.4% | 0.07% | -34.5% |
| Q3 2021 | $215,243,000 | -46.9% | 3,940,731 | -28.5% | 0.11% | -42.6% |
| Q2 2021 | $405,261,000 | -24.0% | 5,515,262 | -5.4% | 0.20% | -33.9% |
| Q1 2021 | $533,221,000 | +37.0% | 5,830,101 | +21.4% | 0.30% | +37.3% |
| Q4 2020 | $389,271,000 | +114.6% | 4,801,656 | +23.2% | 0.22% | +73.6% |
| Q3 2020 | $181,381,000 | – | 3,896,475 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |